EGRP-Supported Epidemiology Consortia

Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers) - Consortium Web Site
	NIH Contacts:
	EGRP/NCI: Scientific Consortia Coordinator & PROSE Liaison: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov Consortia Fellow: Brett Kaminski, M.P.H. brett.kaminski@nih.gov	Lead Investigators: Timothy Rebbeck, Ph.D. University of Pennsylvania trebbeck@cceb.med.upenn.edu

Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers) - Consortium Web Site

NIH Contacts:

EGRP/NCI:

Scientific Consortia Coordinator &
PROSE Liaison:
Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Brett Kaminski, M.P.H.
brett.kaminski@nih.gov

Lead Investigators:

Timothy Rebbeck, Ph.D.
University of Pennsylvania
trebbeck@cceb.med.upenn.edu

View active grants and publications related to the Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies)

Key to Acronyms Used in Tables
EGRP	Epidemiology and Genomics Research Program
CDC	Centers for Disease Control and Prevention
DCB	Division of Cancer Biology
DCEG	Division of Cancer Epidemiology and Genetics
NCI	National Cancer Institute
NHGRI	National Human Genome Research Institute
NIEHS	National Institute of Environmental Health Sciences
NIH	National Institutes of Health
OCS	Office of Cancer Survivorship
OD	Office of the Director